Lv2
180 积分 2023-12-21 加入
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer
1天前
已完结
Completion axillary lymph node dissection for the identification of pN2–3 status as an indication for adjuvant CDK4/6 inhibitor treatment: a post-hoc analysis of the randomised, phase 3 SENOMAC trial
2个月前
已完结
Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial
2个月前
已关闭
Axillary Surgery in Breast Cancer — Primary Results of the INSEMA Trial
2个月前
已完结
Sentinel Node Biopsy for Early Breast Cancer—A SOUND for De-escalation
2个月前
已完结
Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives
5个月前
已完结
Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
5个月前
已完结
Oligometastatic Breast Cancer: Seeking the Cure by Redefining Stage IV Disease?
6个月前
已完结
Pathological Exploration of the Axillary Soft Tissue Microenvironment and Its Impact on Axillary Management and Breast Cancer Outcomes
1年前
已完结
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial
1年前
已完结
皖公网安备34019202002308
